e-Drug3D 739 |
ACARBOSE
|
cas 56180-94-0 |
CLASS METABOLISM |
ROUTE (list) ORAL |
PK parameters F 2 PERCENT Solubility SOLUBLE IN WATER |
Target TARGET LYSOSOMAL ALPHA-GLUCOSIDASE PANCREATIC ALPHA-AMYLASE PDB Ligand code = ACR (link to the list of PDB complexes) Download experimental 3D coordinates of ACR with added hydrogens |
DrugCentral Maltase-glucoamylase, intestinal UNIPROT O43451 MGAM Pancreatic alpha-amylase UNIPROT P04746 AMY2A |
Download SDF file | (2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol Formula: Calculated chemical properties: MW 645.60 NB_atoms 44 XLogP -8.56 PSA 313.947 NB_HD 14 NB_HA 19 fsp3 0.92 Lipinski(0=no;1=yes) 0 |
FDA NDA 020482 (label) INN (ACARBOSE) PRECOSE (BAYER HLTHCARE) APPROVAL= AP YEAR= 1995 DISCONTINUED NDA 077532 (pdf not found) INN (ACARBOSE) ACARBOSE (WATSON LABS) APPROVAL= AP YEAR= 2008 NDA 078470 (pdf not found) INN (ACARBOSE) ACARBOSE (HIKMA) APPROVAL= AP YEAR= 2008 NDA 078441 (pdf not found) INN (ACARBOSE) ACARBOSE (IMPAX LABS) APPROVAL= AP YEAR= 2009 NDA 091053 (pdf not found) INN (ACARBOSE) ACARBOSE (DASH PHARMS) APPROVAL= AP YEAR= 2011 DISCONTINUED NDA 090912 (pdf not found) INN (ACARBOSE) ACARBOSE (STRIDES PHARMA) APPROVAL= AP YEAR= 2011 NDA 202271 (pdf not found) INN (ACARBOSE) ACARBOSE (AVET LIFESCIENCES) APPROVAL= AP YEAR= 2012 NDA 091343 (pdf not found) INN (ACARBOSE) ACARBOSE (SOMERSET THERAPS LLC) APPROVAL= AP YEAR= 2013 NDA 213821 (pdf not found) INN (ACARBOSE) ACARBOSE (HANGZHOU ZHONGMEI) APPROVAL= AP YEAR= 2020 DISCONTINUED |
Other links: |